Media News

Rayence unveils the first X-ray detector technology utilizing SPAD technology

Presenting the cutting-edge detector technology, 'SPAD-GS', which is 2.5 times more sensitive to X-rays and 4 times faster than ever Implemented the world's first X-ray detector using the 'SPAD', digital pixel technology capable of single-photon detection Being announced and drawing attention from the academic world at ISSCC 2023 SEOUL, South Korea, Feb. 23, 2023 /PRNewswire/ --...

Zhongchao Inc. Renews Partnership with Johnson & Johnson (China)

SHANGHAI, Feb. 23, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services to patients with oncology and other major diseases, today announced the renewal of the partnership between Zhongchao Medical Technology (Shanghai) Co., Ltd. ("Zhongchao Shanghai"), of which Zhongchao consolidates the operations and financial results through a series of...

Remidio’s Revolutionary AI on a smartphone for Referable Diabetic Retinopathy (DR) Receives EU MDR Class II Regulatory Approval

World's first Smartphone based offline AI expands geographical scope to deliver convenience and increase access to DR screening. BANGALORE, India, Feb. 23, 2023 /PRNewswire/ -- Remidio has received CE mark approval for its Medios AI, to detect Referable DR. This approval closely follows the nod the AI received from Singapore's Health Sciences...

Xspray Pharma Partners with EVERSANA® for the U.S. Launch and Commercialization of its Lead Product, Dasynoc (XS004) for the Treatment of Chronic Myeloid Leukemia (CML) and Acute Lymphatic Leukemia...

STOCKHOLM, Feb. 23, 2023 /PRNewswire/ -- Xspray Pharma AB, (NASDAQ Stockholm: XSPRAY) has signed an agreement with EVERSANA® to support the U.S. launch and commercialization of the company's first innovative cancer therapy Dasynoc for the treatment of chronic myeloid leukemia (CML) and acute lymphatic leukemia (ALL). While maintaining financial and strategic control,...

World-renowned therapist and wellness expert Marisa Peer endorses natural prebiotic Kfibre & Kfibre Pro Synbiotics for advanced gut health management.

Heal the Gut, Heal the Mind  SYDNEY, Feb. 23, 2023 /PRNewswire/ -- As a pioneering therapist, speaker, best-selling author, and the founder of Rapid Transformational Therapy (RTT®), Marisa's guiding ethos is centred on simple steps that produce dramatic and life-saving results. One of those steps, she recently revealed, is Kfibre Original and...

Keymed and Lepu Biopharma Jointly Announce Global Exclusive Licence Agreement with AstraZeneca for CMG901

CHENGDU, China, Feb. 23, 2023 /PRNewswire/ -- Keymed Biosciences Inc., ("Keymed") (Stock Code: 02162 HK) and Lepu Biopharma Co., Ltd, (Stock Code: 02157.HK) today jointly announce a global exclusive licence agreement with AstraZeneca (LSE/STO/Nasdaq: AZN) for CMG901, a potential first-in-class Claudin 18.2 antibody drug conjugate (ADC). Under the licence agreement, AstraZeneca will be responsible for the research, development, manufacture and commercialisation...

Lepu Biopharma and Keymed Jointly Announces Global Exclusive Licence Agreement with AstraZeneca for CMG901

HONG KONG, Feb. 22, 2023 /PRNewswire/ -- Lepu Biopharma Co., Ltd. (Stock Code: 02157.HK) and Keymed Biosciences Inc., ("Keymed") (Stock Code: 02162 HK) today jointly announces a global exclusive licence agreement with AstraZeneca (LSE/STO/Nasdaq: AZN) for CMG901, a potential first-in-class Claudin 18.2 antibody drug conjugate (ADC). Under the licence agreement, AstraZeneca will be responsible for the research, development, manufacture and commercialisation of...

Dawn Health partners with leading pharmaceutical company to transform chronic care

COPENHAGEN, Denmark, Feb. 23, 2023 /PRNewswire/ -- Dawn Health, a global leader in digital health, today announced a strategic partnership with Novartis, one of the leading medicines companies in the world, to support the development of a platform that enables the effective remote monitoring and management of patients to realize a hybrid future for chronic care and transform the experience...

Trip.com Group aids community recovery through Turkish earthquake relief initiative

SHANGHAI, Feb. 23, 2023 /PRNewswire/ -- Trip.com Group, a leading global online travel services provider, is offering aid and assistance to help support victims of the devastating Turkey-Syria earthquakes that have affected communities throughout the country.  Trip.com Group has donated 3,400 emergency supply packages - including sleeping bags, folding beds, blankets, and moisture-proof...

EVERSANA CONSULTING Named a Top Ranked Consulting Firm by Vault Across Asia Pacific

SINGAPORE and CHICAGO, Feb. 22, 2023 /PRNewswire/ -- EVERSANA®, a pioneer of next-generation commercial services to the global life sciences industry, today announced its strategic consulting arm EVERSANA® CONSULTING, has been named to Vault's 2023 Top Consulting Ranking in the Asia Pacific (APAC) region. The EVERSANA CONSULTING APAC team ranked in the Top...